PHLT
Performant Healthcare Inc
$
7.630
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
7.670
Open
7.620
VWAP
7.62
Vol
3.24M
Mkt Cap
602.75M
Low
7.600
Amount
24.68M
EV/EBITDA(TTM)
92.55
Total Shares
79.00M
EV
601.67M
EV/OCF(TTM)
125.19
P/S(TTM)
4.38
Performant Healthcare, Inc. supports payers in the healthcare industry by identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and proprietary data assets. The Company works with national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB), services as well as claims-based services. Its eligibility-based services involve identifying and recovering payments in situations where its client should not be the primary payer of healthcare claims because a member has other forms of insurance coverage, while its claims-based services include the audit and identification of improperly paid claims. The Company provides these services in both government and commercial healthcare markets. It also provides advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments.
Show More
4 Analyst Rating
Wall Street analysts forecast PHLT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHLT is 7.75 USD with a low forecast of 7.75 USD and a high forecast of 7.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
4 Hold
0 Sell
Hold
Current: 7.630
Low
7.75
Averages
7.75
High
7.75
Current: 7.630
Low
7.75
Averages
7.75
High
7.75
Lake Street
Buy
to
Hold
downgrade
$8
2025-08-04
Reason
Lake Street
Price Target
$8
2025-08-04
downgrade
Buy
to
Hold
Reason
Lake Street downgraded Performant Healthcare to Hold from Buy with a price target of $7.75, down from $8, after the company agreed to be acquired by competitor Machinify for $7.75 per share in cash.
Citizens JMP
Outperform -> Market Perform
downgrade
2025-08-01
Reason
Citizens JMP
Price Target
2025-08-01
downgrade
Outperform -> Market Perform
Reason
Citizens JMP downgraded Performant Healthcare to Market Perform from Outperform without a price target after the company entered into an agreement to be acquired by Machinify for approximately $670M or $7.75 in cash per share.
Citizens JMP
Outperform
initiated
$8
2025-07-10
Reason
Citizens JMP
Price Target
$8
2025-07-10
initiated
Outperform
Reason
Citizens JMP initiated coverage of Performant Healthcare with an Outperform rating and $8 price target. The firm says Performant is a leading technology-enabled healthcare payment integrity vendor. The company is currently implementing its first-ever state Medicaid recovery audit contractor ward in New York, which positions it well for other state-based opportunities, the analyst tells investors in a research note. Citizens is constructive on Performant's capabilities and the model's ability to extend services across a diverse set of payor types.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Performant Healthcare Inc (PHLT.O) is -179.53, compared to its 5-year average forward P/E of -62.06. For a more detailed relative valuation and DCF analysis to assess Performant Healthcare Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-62.06
Current PE
-179.53
Overvalued PE
-10.93
Undervalued PE
-113.18
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Strongly Overvalued
5Y Average EV/EBITDA
29.99
Current EV/EBITDA
51.62
Overvalued EV/EBITDA
39.57
Undervalued EV/EBITDA
20.40
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Overvalued
5Y Average PS
2.08
Current PS
4.31
Overvalued PS
3.03
Undervalued PS
1.12
Financials
Annual
Quarterly
FY2025Q2
YoY :
+28.75%
37.80M
Total Revenue
FY2025Q2
YoY :
-198.10%
2.64M
Operating Profit
FY2025Q2
YoY :
-169.36%
2.08M
Net Income after Tax
FY2025Q2
YoY :
-175.00%
0.03
EPS - Diluted
FY2025Q2
YoY :
-123.26%
-867.00K
Free Cash Flow
FY2025Q2
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q2
YoY :
+3100.00%
-0.32
FCF Margin - %
FY2025Q2
YoY :
-153.92%
5.50
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
2
272.5K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
PHLT News & Events
Events Timeline
2025-08-04 (ET)
2025-08-04
07:27:33
Performant Healthcare downgraded to Hold from Buy at Craig-Hallum
2025-08-04
04:48:40
Performant Healthcare downgraded to Neutral from Buy at B. Riley
2025-08-01 (ET)
2025-08-01
08:57:19
Performant Healthcare to be acquired by Machinify for $670M
Sign Up For More Events
Sign Up For More Events
News
7.0
08-18PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, AMWD, SPTN on Behalf of Shareholders
7.0
08-14GlobenewswirePerformant Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm
7.0
08-13GlobenewswireINVESTIGATION ALERT: Halper Sadeh LLC Continues to Investigate HBI, AMWD, SPNS, and PHLT on Behalf of Shareholders
Sign Up For More News
People Also Watch
META
Meta Platforms Inc
738.700
USD
-1.65%
AAPL
Apple Inc
232.140
USD
-0.18%
TSLA
Tesla Inc
333.870
USD
-3.50%
AMZN
Amazon.com Inc
229.000
USD
-1.12%
NVDA
NVIDIA Corp
174.180
USD
-3.32%
MSFT
Microsoft Corp
506.690
USD
-0.58%
XOM
Exxon Mobil Corp
114.290
USD
+0.83%
ORCL
Oracle Corp
226.130
USD
-5.90%
AVGO
Broadcom Inc
297.390
USD
-3.65%
WMT
Walmart Inc
96.980
USD
+0.91%
FAQ
What is Performant Healthcare Inc (PHLT) stock price today?
The current price of PHLT is 7.63 USD — it has increased 0.39 % in the last trading day.
What is Performant Healthcare Inc (PHLT)'s business?
What is the price predicton of PHLT Stock?
What is Performant Healthcare Inc (PHLT)'s revenue for the last quarter?
What is Performant Healthcare Inc (PHLT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Performant Healthcare Inc (PHLT)'s fundamentals?
How many employees does Performant Healthcare Inc (PHLT). have?